Tag Archives: ATRS

Analysts’ Top Healthcare Picks: ATRS, DRRX

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Antares Pharma (NASDAQ: ATRS) and Durect Corp (NASDAQ: DRRX) with bullish sentiments. Antares Pharma (NASDAQ: ATRS) Antares Pharma (NASDAQ: ATRS) received a

Jefferies Thinks Antares Pharma’s Stock is Going to Recover

According to The Fly, jefferies analyst Anthony Petrone reiterated a Buy rating on Antares Pharma (NASDAQ: ATRS) today and set a price target of $3. The company’s shares opened today at $0.92, close to its 52-week low of $0.67. Petrone

A Director at Antares Pharma (NASDAQ: ATRS) is Buying Shares

Today, a Director at Antares Pharma (NASDAQ: ATRS), Marvin Samson, bought shares of ATRS for $36k. Marvin Samson increased his holding by 94.74%. In addition to Marvin Samson, 5 other ATRS executives reported Buy trades in the last month. Based

A Director at Antares Pharma (NASDAQ: ATRS) is Buying Shares

Today, a Director at Antares Pharma (NASDAQ: ATRS), Thomas Garrity, bought shares of ATRS for $21.6k. Thomas Garrity increased his holding by 23.04%. In addition to Thomas Garrity, 5 other ATRS executives reported Buy trades in the last month. Based

The SVP & CFO of Antares Pharma (NASDAQ: ATRS) is Buying Shares

Today, the SVP & CFO of Antares Pharma (NASDAQ: ATRS), James Fickenscher, bought shares of ATRS for $97.2k. James Fickenscher increased his holding by 99.84%. In addition to James Fickenscher, 3 other ATRS executives reported Buy trades in the last

A Director at Antares Pharma (NASDAQ: ATRS) is Buying Shares

Today, a Director at Antares Pharma (NASDAQ: ATRS), Anton Gueth, bought shares of ATRS for $36k. Anton Gueth increased his holding by 19.78%. In addition to Anton Gueth, 3 other ATRS executives reported Buy trades in the last month. Based